Katja Rohwedder

1.9k citations
35 papers · 1.3k indexed · 1 hit paper · h-index 12
Topics
Diabetes Treatment and Management (21 papers)Hormonal Regulation and Hypertension (13 papers)Metabolism, Diabetes, and Cancer (12 papers)

In The Last Decade

Katja Rohwedder

24 papers receiving 1.3k citations

Hit Papers

Dapagliflozin Versus Glipizide as Add-on Therapy in Patie...20112026201620212011100200300400

Peers

Katja Rohwedder
Comparison fields: 5 of 64
  • Endocrinology, Diabetes and Metabolism 1.2k
  • Molecular Biology 698
  • Surgery 577
  • Pharmacology 275
  • Cardiology and Cardiovascular Medicine 81
Replace Ludwig Merker with:
Ludwig Merker Germany
S. Durán‐García Spain
Zin Zin Htike United Kingdom
Elke Seewaldt-Becker Germany
Silvina Gallo United States
Paul Strumph United States
Lin Ping United States
Yoshishige Samukawa Japan
Michaël J.B. van Baar Netherlands
Julie Derving Karsbøl Denmark
Katja Rohwedder relative to Ludwig Merker Germany Ludwig Merker's profile →
Citations per field
00.5×1.5×
Ludwig Merker · 1×
Citations per year

Countries citing papers authored by Katja Rohwedder

Since Specialization
Citations

This map shows the geographic impact of Katja Rohwedder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katja Rohwedder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katja Rohwedder more than expected).

Fields of papers citing papers by Katja Rohwedder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katja Rohwedder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katja Rohwedder. The network helps show where Katja Rohwedder may publish in the future.

Co-authorship network of co-authors of Katja Rohwedder

This figure shows the co-authorship network connecting the top 25 collaborators of Katja Rohwedder. A scholar is included among the top collaborators of Katja Rohwedder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katja Rohwedder. Katja Rohwedder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 0
5 0
6 1
7 0
8 0
9 2
10 9
11 3
12 1
13 19
14 33
15 10
16 1
17 9
18 6
19
Long-Term Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Receiving High Doses of Insulin
25
20
Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metforminbreakdown →
427

About Katja Rohwedder

Katja Rohwedder is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Nephrology, having authored 35 papers that have together received 1.3k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (21 papers), Hormonal Regulation and Hypertension (13 papers) and Metabolism, Diabetes, and Cancer (12 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.2k citations), Pharmacology (275 citations) and Surgery (577 citations). Katja Rohwedder has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Shamik Parikh, Stefano Del Prato, Michael A. Nauck, S. Durán‐García, Jennifer Sugg, M. Elze, Juris J. Meier, Vincent Woo, John Wilding and Keith Bowering. Their work appears in journals such as Circulation, Annals of Internal Medicine and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026